Efficacy of methylcobalamin in subclinical uraemic neuropathy as detected by measuring vibration perception thresholds

Nephrology

Volumn 2, Issue 1, 1996, Pages 25-28

  Koyama, Katsushi ^a   Yoshida, Atsuhiro ^a   Takeda, Asami ^a   Morozumi, Kunio ^b   Fujinami, Takao ^b  

^a NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Methylcobalamin; Uraemic neuropathy; Vibration perception thresholds

Indexed keywords

EID: 0344703453     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.1996.tb00062.x     Document Type: Article

References (11)

1. Asbury AK. Uremic neuropathy. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R (eds) Peripheral Neuropathy. WB Saunders, Philadelphia 1984; 1811-25.
2. Fraser CL, Arieff AI. Nervous system complications in uremia. Ann. Intern. Med. 1988; 109: 143-55.
3. Charra B, Calemard E, Lawrent G. Chronic renal failure treatment duration and mode: Their relevance to the late dialysis periarticular syndrome. Blood Purif. 1988; 6: 117-24.
4. Nielsen VK. The peripheral nerve function in chronic renal failure. VII. Longitudinal course during terminal renal failure and regular hemodialysis. Acta Med. Scan. 1974; 195: 155-62.
5. Taniguchi T, Ejiri K, Baba S. Improvement of autonomic neuropathy after Mecohalamin treatment in uremic patients on hemodialysis. Clin. Ther. 1987; 9: 607-14.
6. Suzuki Y, Matsuoka K, Atsumi Y, Hosokawa K. Usefulness of new vibrometer SMV-5 and new heart rate variation analyzer SRR5. In: Huh KB (ed.) Insulin Resistance in Human Disease. Tokyo: Elsevier Science Publishers, 1993; 351-5.
7. Nielsen VK. The peripheral nerve function in chronic renal failure. VI. The relationship between sensory and motor nerve conduction and kidney function, azotemia, age, sex and clinical neuropathy. Acta Med. Scan. 1973; 195: 455-62.
8. Di Paolo B, Cappelli P, Spisni C et al. New electrophysiological assessments for the early diagnosis of encephalopathy and peripheral neuropathy in chronic uremia. Int. J. Tissue React. 1982; 4: 301-7.
9. Wilson J, Linnel JC, Matthews DM. Plasma-cohalamin in neuroophthalmological diseases. Lancet 1971; 1: 259-61
10. Wilson J. Leber's hereditary optic atrophy: A possible defect of cyanide metabolism. Clin. Sci. 1965; 29: 505-15.
11. Wilson J. Leber's hereditary optic atrophy. Some clinical and aetiological considerations. Brain 1965; 86: 347-62.